Development and Validation of a Curability Evaluation Model for Endoscopic Resection of Early Esophageal Squamous Cell Carcinoma Based on China Early Esophageal Cancer Cohort

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

With the development of endoscopy, more and more patients with superficial esophageal squamous cell carcinoma (ESCC) receive endoscopic resection rather than traditional surgery. However, there is still no complete consensus on the risk factors for lymph node metastasis (LNM) and recurrence of ESCC after endoscopic resection. The existing curative resection criteria are strict to a certain extent, and a considerable number of patients are overtreated according to the current standard of additional treatment. Thus, we aim to conduct a multi-center retrospective and prospective study to construct a large cohort of ESCC based on the previously established multi-center collaborative research network and clinical big data, analyze the risk factors of LNM and recurrence in patients with early esophageal squamous cell carcinoma after ESD, establish an accurate and simple risk prediction model, and evaluate the discrimination efficiency of this model.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 15
Maximum Age: 85
Healthy Volunteers: f
View:

• Men and women, aged 18-85.

• ESD was performed for early (superficial) esophageal squamous cell carcinoma, and the indication was in line with domestic and foreign guidelines.

• The pathological stage after ESD was pT1a/pT1b.

• The effective follow-up time after ESD was ≥3 years, or recurrence or LNM occurred during the follow-up period.

Locations
Other Locations
China
Changhai Hospital
RECRUITING
Shanghai
Contact Information
Primary
Luowei Wang, Doctor
wangluoweimd@126.com
13901833088
Time Frame
Start Date: 2022-10-01
Estimated Completion Date: 2025-10-01
Participants
Target number of participants: 1000
Related Therapeutic Areas
Sponsors
Collaborators: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The Second Hospital of Hebei Medical University, Tongliao City Hospital, Jiangsu Province Hospital of Traditional Chinese Medicine, The second affiliated hospital of Xuzhou medical university, West China Hospital, The Second Affiliated Hospital of Baotou Medical College, The First Affiliated Hospital with Nanjing Medical University, Anyang Cancer Hospital, Lianshui People's Hospital, The second people's hospital of Nanyang, Zhongda Hospital, Sichuan Cancer Hospital and Research Institute, Shanxi Provincial People's Hospital, Henan Provincial People's Hospital, Yancheng First People's Hospital, The First Affiliated Hospital of Soochow University, Affiliated Hospital of Southwest Medical University, Nanchong Central Hospital, Shandong Provincial Hospital
Leads: Changhai Hospital

This content was sourced from clinicaltrials.gov

Similar Clinical Trials